Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

Affiliations

• ¹ Department of Nuclear Medicine, Aix-Marseille University, La Timone University Hospital, Marseille, France.
• ² Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
• ³ Department of Medicine IV, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
• ⁴ Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
• ⁵ Department of Medicine, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany.
• ⁶ Molecular Imaging and Therapy Service, Radiology Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁷ Green Templeton College, University of Oxford, Oxford, UK.
• ⁸ NET Unit, Royal Free Hospital, London, UK.
• ⁹ Department of Endocrinology, Royal North Shore Hospital and Cancer Genetics Laboratory, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia.
• ¹⁰ Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹¹ Université Paris Cité, Inserm, PARCC, Equipe Labellisée par la Ligue contre le Cancer, Paris, France.
• ¹² Hypertension Unit, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France.
• ¹³ Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
• ¹⁴ Department of Medical Genetics, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
• ¹⁵ Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
• ¹⁶ Research Center, CHU Sainte-Justine and Dept. of Paediatrics, University of Montreal, Montreal, Québec, Canada.
• ¹⁷ Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ¹⁸ Department of Surgery, UCSF-Mount Zion, San Francisco, CA, USA.
• ¹⁹ Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany.
• ²⁰ Columbia University Irving Medical Center, New York City, NY, USA.
• ²¹ James J. Peters VA Medical Center, New York City, NY, USA.
• ²² Division of Endocrinology & Metabolism, Department of Medicine, University of Florida, Gainesville, FL, USA.
• ²³ Malcom Randall VA Medical Center, Gainesville, FL, USA.
• ²⁴ Department of Oncogenetics and Cancer Genomic Medicine, AP-HP, Hôpital européen Georges Pompidou, Paris, France.
• ²⁵ University of Sydney, Sydney NSW Australia, Cancer Diagnosis and Pathology Group Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
• ²⁶ NSW Health Pathology Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
• ²⁷ Department of Medicine, St Vincent's Hospital Medical School, Melbourne, Victoria, Australia.
• ²⁸ Department of Nuclear Medicine and Molecular Imaging - Institut de Cancérologie de Strasbourg Europe (ICANS), IPHC, UMR 7178, CNRS, University of Strasbourg, Strasbourg, France.
• ²⁹ Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
• ³⁰ Department of Endocrinology, University Medical Center Groningen, Groningen, Netherlands.
• ³¹ Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands.
• ³² Princess Máxima Center for paediatric oncology, Utrecht, Netherlands.
• ³³ Division of Endocrinology, Department of Medicine, Centre de recherche du Centre hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Canada.
• ³⁴ Department of Internal Medicine 1, University Hospital, P.J. Šafárik University, Košice, Slovakia.
• ³⁵ Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ³⁶ Sorbonne University, Department of Nuclear Medicine, Pitié-Salpêtrière, Paris, France.
• ³⁷ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
• ³⁸ Clinical Research Institute of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center and Endocrine Center, Kyoto, Japan.
• ³⁹ Clinical Research Center, Ijinkai Takeda General Hospital, Kyoto, Japan.
• ⁴⁰ Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ⁴¹ Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
• ⁴² Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
• ⁴³ Department of Endocrine Surgery, Aix-Marseille University, Conception Hospital, Marseille, France.
• ⁴⁴ Department of Endocrinology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
• ⁴⁵ Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁴⁶ Division of Endocrine Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
• ⁴⁷ Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
• ⁴⁸ Third Department of Medicine, Department of Endocrinology and Metabolism of the First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
• ⁴⁹ Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, USA.
• ⁵⁰ Stanford University School of Medicine, Department of Physician Assistant Studies, Stanford, CA, USA.
• ⁵¹ Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. [email protected].